InGeneron Competitors and Similar CompaniesClear all
InGeneron's competitors and similar companies include Celling Biosciences, Cambium Bio, Sernova and Cells for Cells.
 InGeneron InGeneron is a cell therapy company that offers treatments designed to heal certain chronic conditions using a patient’s own regenerative cells. |  Celling Biosciences Celling Biosciences is a company developing point-of-care systems, surgical techniques, and technology platforms that create the optimal environment for regenerative cell therapies. |  Cambium Bio Cambium Bio (formerly known as Regeneus) is a regenerative medicine company developing a portfolio of cell-based therapies with a focus on osteoarthritis (OA), neuropathic pain, and dermatology. |  Sernova Sernova Biotherapeutics (formerly Sernova Corp.) is a regenerative medicine technology company developing products for the treatment of chronic diseases such as diabetes and hemophilia. |  Cells for Cells Cells for Cells is a biotechnology company dedicated to the research, development, and commercialization of cellular therapies. | |
Founding Date | Founding Date 2006 | Founding Date 2013 | Founding Date 2007 | Founding Date 2006 | Founding Date 2010 |
Type | Type Private | Type Private | Type Public | Type Public | Type Private |
Tags | |||||
Locations | Locations Houston, US HQ München, DE | Locations Austin, US HQ Curitiba, BR Dubai, AE | Locations Paddington, AU HQ Pymble, AU | Locations London, CA HQ | Locations Las Condes, CL HQ |
Employees | Employees 16 | Employees 47 | Employees N/A | Employees N/A | Employees 264% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 2.4 m | Valuation ($) 318.3 m | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $670k (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit $1.2m (FY, 2025) | Gross profit N/A | Gross profit N/A |
Net income | Net income N/A | Net income N/A | Net income ($3.8m) (FY, 2025) | Net income ($32.2m) (FY, 2024) | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised $ 47.5m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 6.3m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Celling Biosciences
HQ
Austin, US
Employees
47
Celling Biosciences is a company developing point-of-care systems, surgical techniques, and technology platforms that create the optimal environment for regenerative cell therapies.
View companyCambium Bio
HQ
Paddington, AU
Cambium Bio (formerly known as Regeneus) is a regenerative medicine company developing a portfolio of cell-based therapies with a focus on osteoarthritis (OA), neuropathic pain, and dermatology.
View companySernova
HQ
London, CA
Sernova Biotherapeutics (formerly Sernova Corp.) is a regenerative medicine technology company developing products for the treatment of chronic diseases such as diabetes and hemophilia.
View companyCells for Cells
HQ
Las Condes, CL
Employees
26↑ 4% increase
Cells for Cells is a biotechnology company dedicated to the research, development, and commercialization of cellular therapies.
View company